Keyphrases
Cancer Cells
100%
In Cancer
100%
Oncolysis
100%
Interferon Response
100%
Vesicular Stomatitis Virus
100%
ERK Pathway
100%
RAF1
100%
Interferon-α (IFN-α)
85%
U0126
57%
MEK-ERK Pathway
28%
Malignant Cells
28%
Overexpressing
14%
Human Cancer
14%
All Cancer
14%
Virus Infection
14%
Oncolytic Virus
14%
Primary Cells
14%
Mitogen-activated Protein Kinase
14%
Constitutive Activation
14%
Stably Expressing
14%
NIH3T3
14%
Pregenomic RNA (pgRNA)
14%
Infected Cells
14%
Dual Treatment
14%
Cell-less
14%
RNA Synthesis
14%
Interferon Treatment
14%
MEK Inhibitor (MEKi)
14%
Virus RNA
14%
Interferon System
14%
Selective Replication
14%
Extracellular Regulated Protein Kinases
14%
MxA Protein
14%
Medicine and Dentistry
Interferon
100%
Cancer Cell
100%
Vesiculovirus
100%
Cell Signaling Pathway
100%
U0126
44%
Cancer
22%
Virus RNA
22%
Malignant Neoplasm
11%
Virus Infection
11%
Oncolytic Virus
11%
Upregulation
11%
Cell Line
11%
Protein Kinases
11%
RNA Synthesis
11%
Myxovirus Resistance Protein A
11%
Mitogen Activated Protein Kinase Kinase
11%
MEK Inhibitor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Interferon
100%
Vesiculovirus
100%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
44%
Virus RNA
22%
Virus Infection
11%
Protein Kinases
11%
Oncolytic Virus
11%
Mitogen Activated Protein Kinase Kinase
11%
Mitogen Activated Protein Kinase Kinase Inhibitor
11%
Myxovirus Resistance Protein A
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Vesiculovirus
100%
Interferon
100%
U0126
44%
Protein Kinases
11%
Upregulation
11%
RNA
11%
Primary Cell
11%
RNA Synthesis
11%
Mitogen-Activated Protein Kinase Kinase
11%
MEK Inhibitor
11%
RNA Virus
11%
Immunology and Microbiology
interferon
100%
Cancer Cell
100%
Vesiculovirus
100%
Viral Disease
11%
Mitogen
11%
Oncolytic Virus
11%
Upregulation
11%
Cell Line
11%
RNA Synthesis
11%
RNA Virus
11%